Endovascular versus Medical Management of Acute Basilar Artery Occlusion: A Systematic Review and Meta-Analysis of the Randomized Controlled Trials.
Acute basilar artery occlusion
Acute stroke
Meta-analysis
Posterior circulation
Journal
Journal of stroke
ISSN: 2287-6391
Titre abrégé: J Stroke
Pays: Korea (South)
ID NLM: 101602023
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
29
11
2022
accepted:
06
01
2023
entrez:
6
2
2023
pubmed:
7
2
2023
medline:
7
2
2023
Statut:
ppublish
Résumé
The optimal management of patients with acute basilar artery occlusion (BAO) is uncertain. We aimed to evaluate the safety and efficacy of endovascular thrombectomy (EVT) compared to medical management (MM) for acute BAO through a meta-analysis of randomized controlled trials (RCTs). We performed a systematic review and meta-analysis of RCTs of patients with acute BAO. We analyzed the pooled effect of EVT compared to MM on the primary outcome (modified Rankin Scale [mRS] of 0-3 at 3 months), secondary outcome (mRS 0-2 at 3 months), symptomatic intracranial hemorrhage (sICH), and 3-month mortality rates. For each study, effect sizes were computed as odds ratios (ORs) with random effects and Mantel-Haenszel weighting. Four RCTs met inclusion criteria including 988 patients. There were higher odds of mRS of 0-3 at 90 days in the EVT versus MM group (45.1% vs. 29.1%, OR 1.99, 95% confidence interval [CI] 1.04-3.80; P=0.04). Patients receiving EVT had a higher sICH compared to MM (5.4% vs. 0.8%, OR 7.89, 95% CI 4.10-15.19; P<0.01). Mortality was lower in the EVT group (35.5% vs. 45.1%, OR 0.64, 95% CI 0.42-0.99; P=0.05). In an analysis of two trials with BAO patients and National Institutes of Health Stroke Scale (NIHSS) <10, there was no difference in 90-day outcomes between EVT versus MM. In this systematic review and meta-analysis, EVT was associated with favorable outcome and decreased mortality in patients with BAO up to 24 hours from stroke symptoms compared to MM. The treatment effect in BAO patients with NIHSS <10 was less certain. Further studies are of interest to evaluate the efficacy of EVT in basilar occlusion patients with milder symptoms.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
The optimal management of patients with acute basilar artery occlusion (BAO) is uncertain. We aimed to evaluate the safety and efficacy of endovascular thrombectomy (EVT) compared to medical management (MM) for acute BAO through a meta-analysis of randomized controlled trials (RCTs).
METHODS
METHODS
We performed a systematic review and meta-analysis of RCTs of patients with acute BAO. We analyzed the pooled effect of EVT compared to MM on the primary outcome (modified Rankin Scale [mRS] of 0-3 at 3 months), secondary outcome (mRS 0-2 at 3 months), symptomatic intracranial hemorrhage (sICH), and 3-month mortality rates. For each study, effect sizes were computed as odds ratios (ORs) with random effects and Mantel-Haenszel weighting.
RESULTS
RESULTS
Four RCTs met inclusion criteria including 988 patients. There were higher odds of mRS of 0-3 at 90 days in the EVT versus MM group (45.1% vs. 29.1%, OR 1.99, 95% confidence interval [CI] 1.04-3.80; P=0.04). Patients receiving EVT had a higher sICH compared to MM (5.4% vs. 0.8%, OR 7.89, 95% CI 4.10-15.19; P<0.01). Mortality was lower in the EVT group (35.5% vs. 45.1%, OR 0.64, 95% CI 0.42-0.99; P=0.05). In an analysis of two trials with BAO patients and National Institutes of Health Stroke Scale (NIHSS) <10, there was no difference in 90-day outcomes between EVT versus MM.
CONCLUSION
CONCLUSIONS
In this systematic review and meta-analysis, EVT was associated with favorable outcome and decreased mortality in patients with BAO up to 24 hours from stroke symptoms compared to MM. The treatment effect in BAO patients with NIHSS <10 was less certain. Further studies are of interest to evaluate the efficacy of EVT in basilar occlusion patients with milder symptoms.
Identifiants
pubmed: 36746382
pii: jos.2022.03755
doi: 10.5853/jos.2022.03755
pmc: PMC9911851
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
81-91Références
Circulation. 2022 Jul 5;146(1):6-17
pubmed: 35656816
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
BMC Neurol. 2019 Dec 6;19(1):315
pubmed: 31810447
Stroke. 2021 Oct;52(10):3410-3413
pubmed: 34517766
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
N Engl J Med. 2013 Mar 7;368(10):893-903
pubmed: 23390923
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
JAMA Neurol. 2020 May 1;77(5):561-573
pubmed: 32080711
Lancet Neurol. 2020 Feb;19(2):115-122
pubmed: 31831388
Stroke. 2014 Jun;45(6):1733-8
pubmed: 24781081
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
Stroke. 2022 Apr;53(4):1247-1255
pubmed: 34905944
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
Eur J Neurol. 2021 Jun;28(6):2106-2110
pubmed: 33482047
J Neuroradiol. 2017 Jun;44(3):198-202
pubmed: 28238522
Lancet Neurol. 2009 Aug;8(8):724-30
pubmed: 19577962
N Engl J Med. 2022 Oct 13;387(15):1373-1384
pubmed: 36239645
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Stroke. 2023 Feb 1;:
pubmed: 36722343
J Stroke. 2021 Jan;23(1):91-102
pubmed: 33600706
N Engl J Med. 2022 Oct 13;387(15):1361-1372
pubmed: 36239644
Neurology. 2022 Mar 22;98(12):486-498
pubmed: 35314513
Lancet. 2022 Jan 15;399(10321):249-258
pubmed: 34774198
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
N Engl J Med. 2021 May 20;384(20):1910-1920
pubmed: 34010530
Stroke. 2023 Jan 23;:
pubmed: 36688315
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
Stroke. 2018 Oct;49(10):2391-2397
pubmed: 30355086
Transl Stroke Res. 2022 Dec;13(6):913-922
pubmed: 35349051
BMC Med Res Methodol. 2014 Feb 18;14:25
pubmed: 24548571
Lancet Neurol. 2016 Oct;15(11):1138-47
pubmed: 27567239
Cerebrovasc Dis. 2005;20(1):12-7
pubmed: 15925877
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Ann Neurol. 2013 Jun;73(6):688-94
pubmed: 23536323
J Stroke Cerebrovasc Dis. 2022 Nov;31(11):106804
pubmed: 36206608
World Neurosurg. 2021 May;149:e400-e414
pubmed: 33578025
J Neuroradiol. 2023 Feb;50(1):42-43
pubmed: 36528085
J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2191-2198
pubmed: 28551292